<?xml version="1.0"?><collection name="D0824-B"><document name="NYT_ENG_20050425.0255"><line>Various chemotherapy drugs are already used for this purpose, which is called adjuvant therapy.<annotation scu-count="0" sum-count="1" sums="47"/></line></document><document name="APW_ENG_20050808.0126"><line>Examining 25 years of cancer records nationwide, researchers concluded that smaller tumor size accounted for 61 percent of the improvement in survival when cancer had not spread beyond the breast, and 28 percent when it had spread just a little.</line></document><document name="LTW_ENG_20050719.0134"><line>The hormone flows most copiously during sleep, thus its nickname, the sleep hormone.</line></document><document name="LTW_ENG_20050817.0111"><line>But with child obesity rates rising, she said, &quot;There are numerous reasons to avoid French fries.&quot;</line></document><document name="LTW_ENG_20050510.0106"><line>&quot;For a long time, people have tried to treat DCIS as one disease, but it is a spectrum that ranges from low to medium to high grade,&quot; Sanders said Monday.</line></document><document name="LTW_ENG_20050817.0111"><line>The association was not found with potatoes prepared in other ways.</line></document><document name="APW_ENG_20050513.0945"><line>Studies have shown that drugs given to prevent cancer's return can improve the survival rates five years after diagnosis and that the effects last at least 10 years.<annotation scu-count="0" sum-count="1" sums="5"/></line></document><document name="NYT_ENG_20050425.0255"><line>Herceptin is already approved as a treatment for breast cancer that has recurred after surgery or that has spread elsewhere in the body.</line></document><document name="APW_ENG_20050513.0945"><line>The risk of dying from breast cancer has been falling rapidly for the past 15 years mainly because the drugs used to treat the disease have been effective at stopping the cancer from returning, according to a major new analysis.</line></document><document name="APW_ENG_20050808.0126"><line>An estimated 211,240 new cases and 40,400 deaths from it are expected this year.</line><line>For regional cancers, survival rose from about 68 percent to about 80 percent, but was only 76 percent once tumor size was factored in.<annotation scu-count="0" sum-count="1" sums="51"/></line></document><document name="LTW_ENG_20050719.0134"><line>The analysis by Boston researchers goes straight to the heart of a question scientists have asked for years: Are night shift workers, because of extended exposure to light, more likely to develop cancer?</line></document><document name="APW_ENG_20050513.0945"><line>The review is the fourth analysis to be conducted by the same group of scientists on the largest database of patients for any type of cancer.</line></document><document name="NYT_ENG_20050829.0289"><line>However, results of UNC researchers show that performing the procedure before treatment provides a more accurate picture of lymph node involvement, Ollila said.<annotation scu-count="0" sum-count="2" sums="19,48"/></line></document><document name="NYT_ENG_20050516.0286"><line>Although the treatments varied, the two groups were equivalent because the women were assigned at random to follow a low-fat diet.</line></document><document name="NYT_ENG_20050829.0289"><line>If the test procedure showed disease in the sentinel node or if the tumor was larger than five centimeters in diameter, all the nodes were removed and the patient received chemotherapy and surgery.</line></document><document name="LTW_ENG_20050719.0134"><line>In her analysis, which involved participants from the Nurses Health Study, urine samples were taken from 147 nurses with invasive breast cancer and 291 matched controls who did not have the disease.</line></document><document name="APW_ENG_20050808.0126"><line>A whopping 96 percent of the survival improvement for women 65 and older with local-stage cancers was explained by this.</line></document><document name="APW_ENG_20050513.0945"><line>In a review published Friday in The Lancet medical journal, researchers led by scientists at Oxford University in England analyzed the combined evidence from 194 studies involving more than 145,000 women with early stage breast cancer who were treated with drugs that were being tested during the 1980s.<annotation scu-count="0" sum-count="2" sums="10,21"/></line></document><document name="NYT_ENG_20050516.0286"><line>&quot;This is the first randomized clinical trial showing that diet may have an impact on breast cancer outcome, or any cancer outcome, for that matter,&quot; Chlebowski said.</line></document><document name="LTW_ENG_20050817.0111"><line>The researchers analyzed data gathered in 1993 from 582 participants with breast cancer and 1,569 women without breast cancer.<annotation scu-count="0" sum-count="4" sums="13,21,22,42"/></line></document><document name="NYT_ENG_20050425.0255"><line>Genentech stock has risen more than 50 percent in the last six weeks and the company is now neck and neck with the larger Amgen as the most valuable company in biotechnology, with a market capitalization of about $73 billion.</line></document><document name="LTW_ENG_20050719.0134"><line>Switch off the lights, and melatonin, secreted by the brain's pineal gland, begins to stream into the blood.</line></document><document name="NYT_ENG_20050829.0289"><line>But new research released this week by the University of North Carolina School of Medicine says a less invasive surgery now used with small tumors is also effective.<annotation scu-count="0" sum-count="1" sums="0"/></line></document><document name="NYT_ENG_20050425.0255"><line>Genentech said that 34,000 women a year get adjuvant treatment for HER2-positive breast cancer in the United States.</line></document><document name="APW_ENG_20050808.0126"><line>Much of the improvement in breast cancer survival in recent years is because the average tumor is smaller, not just because treatments are so much better, a huge new study has found.<annotation scu-count="0" sum-count="7" sums="11,14,19,23,44,48,49"/></line><line>&quot;But not all of the improvement in survival is due to treatment when important characteristics like size have also changed over time.&quot;</line></document><document name="AFP_ENG_20050720.0687"><line>&quot;Our findings indicate a link between select types of benign breast lesions and the later development of breast cancer,&quot; said Lynn Hartmann, an oncologist with the Mayo Clinic who led the study.<annotation scu-count="1" sum-count="2" sums="13,33"><scu uid="5" label="LInk between breast lesions and cancer" weight="3"/></annotation></line></document><document name="LTW_ENG_20050510.0106"><line>&quot;This long natural history means that if this diagnosis is made in a woman 65 or 70 years old, it could be 40 years before she developed cancer.&quot;</line></document><document name="LTW_ENG_20050719.0134"><line>And Dr. David Blask of the Bassett Research Institute in Cooperstown found that melatonin serves as an anticancer signal to human breast cancers.<annotation scu-count="0" sum-count="2" sums="12,44"/></line></document><document name="LTW_ENG_20050817.0111"><line>She speculated the French fries may be implicated in breast cancer because they are prepared in fats that are high in harmful trans-fatty acids and saturated fat.<annotation scu-count="0" sum-count="2" sums="43,55"/></line></document><document name="NYT_ENG_20050516.0286"><line>Of 975 women assigned to a low-fat diet, 96, or 9.8 percent, had recurrences.</line></document><document name="APW_ENG_20050808.0126"><line>Attributing the benefit of smaller tumors to early detection and mammograms &quot;makes a lot of intuitive sense, but that's of course why we do studies as opposed to depend on leaps of logic,&quot; he said.</line></document><document name="APW_ENG_20050513.0945"><line>Earlier reviews assessed the effect of various drugs on recurrence and survival over five and 10 years.</line></document><document name="NYT_ENG_20050829.0289"><line>The sentinel-node biopsy accurately predicted node involvement, Ollila said.</line></document><document name="NYT_ENG_20050425.0255"><line>Dr. Clifford A. Hudis, chief of breast cancer medicine service at Memorial Sloan-Kettering Cancer Center in New York, called the results &quot;big news,&quot; because using the drug in early-stage treatment could have an effect on a greater number of women and perhaps help keep them free of cancer.<annotation scu-count="0" sum-count="1" sums="43"/></line></document><document name="LTW_ENG_20050817.0111"><line>She said dietary influences may be more significant during early life than during adulthood, because the breast of a girl or infant is more susceptible to environmental influences than the breast of a mature woman.</line></document><document name="APW_ENG_20050808.0126"><line>Only 38 percent of the improvement in women under 50 was due to the shift in tumor size.</line></document><document name="NYT_ENG_20050425.0255"><line>But in after-hours trading the stock was up to $76.50.</line></document><document name="AFP_ENG_20050720.0687"><line>More than one million women each year have biopsies of breast lesions that turn up benign, the report said.</line></document><document name="NYT_ENG_20050425.0255"><line>All patients were given chemotherapy and some were also given Herceptin.</line></document><document name="LTW_ENG_20050510.0106"><line>There is debate over radiation treatment and there is a difference over whether you live on the West Coast or the East Coast,&quot; Budman said.</line></document><document name="APW_ENG_20050808.0126"><line>It also shows that older women have benefited from mammograms, Saslow said.</line></document><document name="LTW_ENG_20050817.0111"><line>Each weekly serving of French fries girls consumed between ages 3 and 5 increased their risk of developing breast cancer as adults by 27 percent, according to researchers at Brigham and Women's Hospital and the Harvard School of Public Health.</line></document><document name="LTW_ENG_20050510.0106"><line>The analysis spanned 40 years to finally document &quot;the natural history&quot; of this low-grade cancer -- how long it takes to develop and whether it routinely evolves into invasive breast cancer.</line></document><document name="LTW_ENG_20050719.0134"><line>&quot;But now the evidence is becoming clearer,&quot; that a relationship exists between tumor development and being exposed to light at night, she said.</line></document><document name="LTW_ENG_20050510.0106"><line>Findings revealed that low-grade DCIS developed into invasive cancers in 40 percent of patients with the risk extending over a 40-year period.<annotation scu-count="1" sum-count="1" sums="48"><scu uid="36" label=" Ductal carcinoma can take 40 years to develop" weight="2"/></annotation></line></document><document name="APW_ENG_20050808.0126"><line>The federal government recommends that women over 40 get mammograms every 1 to 2 years, with or without a breast exam by their doctor.</line></document><document name="LTW_ENG_20050510.0106"><line>A form of breast cancer, which under the microscope can sometimes appear as a benign condition, actually carries a 40-year risk of flaring into invasive cancer with a capacity to spread, medical experts say.</line></document><document name="NYT_ENG_20050516.0286"><line>It is not clear, they said, what made the difference.</line></document><document name="NYT_ENG_20050425.0255"><line>&quot;It's one thing to treat a recurrent disease and it's another thing to prevent a recurrence outright,&quot; Hudis said.</line><line>The results of the two new trials, sponsored by the National Cancer Institute, showed that Herceptin reduced recurrences by 52 percent on top of those other therapies.<annotation scu-count="1" sum-count="1" sums="32"><scu uid="1" label="Herceptin reduced HER2-positive gene-associated breast cancer recurrences 52 percent" weight="2"/></annotation></line></document><document name="AFP_ENG_20050525.0641"><line>&quot;This is good news for women with breast cancer,&quot; said Doctor Michelle Holmes, a Harvard Medical School assistant professor who led the study published in the Journal of the Medical Association (JAMA).<annotation scu-count="0" sum-count="2" sums="20,33"/></line></document><document name="APW_ENG_20050513.0945"><line>Although surgery and radiation therapy can seem to wipe out the disease in early-stage breast cancer, undetected cancer cells can remain and unleash a life-threatening recurrence years later.<annotation scu-count="0" sum-count="2" sums="10,42"/></line></document><document name="NYT_ENG_20050829.0289"><line>Dr. Rosa Cuenca, a surgical oncologist at East Carolina University's Brody School of Medicine, said the procedure has been controversial for large tumors.</line></document><document name="LTW_ENG_20050817.0111"><line>The participants were born between 1921 and 1965, so their mothers were being asked to recall information from decades earlier.</line></document><document name="LTW_ENG_20050510.0106"><line>&quot;On the West Coast (doctors) are less likely to use radiation; on the East coast they're more likely to recommend it.&quot;</line></document><document name="NYT_ENG_20050425.0255"><line>Use of Herceptin earlier in breast cancer will mean a bigger market for the drug, which last year had sales of $483 million.</line></document><document name="NYT_ENG_20050516.0286"><line>The study began in 1994 and enrolled 2,437 postmenopausal women with early-stage breast cancer.<annotation scu-count="0" sum-count="2" sums="37,6"/></line></document><document name="NYT_ENG_20050829.0289"><line>&quot;I think any woman diagnosed with breast cancer should ask her physician what role this technique might play in her overall treatment,&quot; Ollila said.</line></document><document name="NYT_ENG_20050425.0255"><line>All were so-called HER2 positive, a reference to the genetic characteristic that makes a patient a candidate for Herceptin.</line></document><document name="AFP_ENG_20050720.0687"><line>However, proliferative lesions that were benign in a biopsy were shown to have a high correlation to the later development of breast cancer.<annotation scu-count="0" sum-count="2" sums="57,6"/></line></document><document name="LTW_ENG_20050817.0111"><line>Consumption of whole milk was associated with a slightly decreased risk of breast cancer, though most of the milk consumed during those decades was whole milk, Michels said.</line></document><document name="LTW_ENG_20050510.0106"><line>Physicians Melinda Sanders and David Page of Vanderbilt University Medical Center in Memphis, Tenn., have conducted the largest analysis to date on the form of DCIS known as low-grade, which because of the appearance of the cells can be mistaken for atypical ductal hyperplasia, a benign disorder.</line></document><document name="NYT_ENG_20050829.0289"><line>Subjects in the study were 21 breast cancer patients with tumors large enough in relation to the size of the breast that the breast could not be preserved.<annotation scu-count="0" sum-count="2" sums="21,36"/></line><line>Detecting the spread of breast cancer in women with large tumors may have just become easier.<annotation scu-count="0" sum-count="2" sums="0,49"/></line></document><document name="NYT_ENG_20050425.0255"><line>These tumors tend to be aggressive and may be less likely to be held in check by tamoxifen, doctors said, so there is a particular need for new ways to treat them.</line></document><document name="APW_ENG_20050808.0126"><line>For example, the number of local-stage breast cancers that were smaller than 1 centimeter rose from less than 10 percent from 1975 through 1979 to 25 percent from 1995 through 1999.<annotation scu-count="0" sum-count="1" sums="5"/></line></document><document name="NYT_ENG_20050829.0289"><line>Lymph node dissection is much like interviewing the eyewitnesses closest to the crime scene.</line></document><document name="APW_ENG_20050513.0945"><line>Dr. Karen Gelmon and colleagues at the British Columbia Cancer Agency in Vancouver, who were not connected with the research, noted, however, that the review analyzed older treatment strategies and did not evaluate newer drugs that are standard therapy today.</line></document><document name="NYT_ENG_20050829.0289"><line>She compares large tumors to wrecked cars on the freeway.</line></document><document name="NYT_ENG_20050425.0255"><line>&quot;If you don't have a recurrence of breast cancer you can't die of the disease.&quot;<annotation scu-count="0" sum-count="2" sums="37,6"/></line><line>The catch is that the results of the clinical trials apply only to the 20 to 30 percent of women whose breast cancer has a particular genetic mutation, because Herceptin works against such tumors only.</line></document><document name="LTW_ENG_20050817.0111"><line>&quot;This is something nobody's really looked at before.</line></document><document name="NYT_ENG_20050425.0255"><line>Other statistics from the trial were not provided.<annotation scu-count="0" sum-count="1" sums="42"/></line></document><document name="NYT_ENG_20050829.0289"><line>The new study from the medical school is published in the September issue of the American Journal of Surgery.</line></document><document name="NYT_ENG_20050425.0255"><line>Indeed, the two trials were stopped about two years early because they had already established that Herceptin cuts recurrences and prolongs survival.<annotation scu-count="1" sum-count="1" sums="48"><scu uid="1" label="Herceptin reduced HER2-positive gene-associated breast cancer recurrences 52 percent" weight="2"/></annotation></line></document><document name="LTW_ENG_20050510.0106"><line>Treatment issues involving all grades of DCIS -- low, medium and high -- have been a source of discussion for years, said Dr. Daniel Budman, associate director of oncology at North Shore University Hospital.</line></document><document name="NYT_ENG_20050516.0286"><line>Breast cancer patients who follow diets low in fat may reduce the chance that their tumors will return, scientists reported Monday.<annotation scu-count="1" sum-count="7" sums="11,23,25,41,44,51,6"><scu uid="3" label="Studies have shown that low-fat diets are effective " weight="4"/></annotation></line></document><document name="APW_ENG_20050513.0945"><line>For women of any age with hormone-sensitive breast cancer _ the most common type _ giving tamoxifen for five years reduced the breast cancer death rate over the next 15 years by about one-third.<annotation scu-count="0" sum-count="1" sums="22"/></line></document><document name="LTW_ENG_20050719.0134"><line>The lowest levels of melatonin's breakdown product were in night shift workers who had developed the cancer, leading Schernhammer to conclude that women with the lowest levels were 70 times more likely to develop breast cancer.</line></document><document name="NYT_ENG_20050425.0255"><line>The two new trials were intended to look at whether the drug might also work earlier in the course of the disease, after a tumor is removed by surgery.</line></document><document name="NYT_ENG_20050516.0286"><line>The study's principal investigator, Dr. Rowan T. Chlebowski of the Los Angeles Biomedical Research Institute in Torrance, Calif., described the data Monday at a meeting of the American Society of Clinical Oncology in Orlando.</line><line>In a telephone interview, Chlebowski explained that the women already had had the standard medical treatment -- lumpectomy or mastectomy followed by radiation and then hormonal therapy or chemotherapy when appropriate.</line></document><document name="NYT_ENG_20050829.0289"><line>&quot;There are a few individual centers using it on large tumors,&quot; said Dr. David W. Ollila, a UNC surgeon and researcher.<annotation scu-count="0" sum-count="1" sums="0"/></line></document><document name="APW_ENG_20050808.0126"><line>However, this is the largest study in American women to look at size within those stages.</line></document><document name="AFP_ENG_20050525.0641"><line>Some 211,000 new cases of breast cancer are diagnosed each year in the United States, and 40,000 die of the disease each year, the second deadliest after lung cancer.<annotation scu-count="0" sum-count="1" sums="40"/></line></document><document name="LTW_ENG_20050719.0134"><line>To further test her theory about light exposure and breast cancer, Schernhammer has embarked on a study of blind women, whose eyes aren't transmitting light to the brain.</line></document><document name="APW_ENG_20050808.0126"><line>But it implies much about the value of early detection.</line></document><document name="LTW_ENG_20050817.0111"><line>Michels said her study doesn't prove that giving up French fries will protect women from breast cancer.<annotation scu-count="0" sum-count="1" sums="42"/></line></document><document name="APW_ENG_20050808.0126"><line>Breast cancer is the most common cancer in American women.<annotation scu-count="0" sum-count="2" sums="22,43"/></line></document><document name="NYT_ENG_20050829.0289"><line>If the biopsy showed tumor-free sentinel nodes and the tumor was less than five centimeters, no further lymph nodes were removed and the patient received chemotherapy and tumor removal.<annotation scu-count="0" sum-count="1" sums="57"/></line></document><document name="AFP_ENG_20050525.0641"><line>The research showed that walking at an average pace for three to five hours a week reduced the risk of death by 50 percent compared to more sedentary women.</line></document><document name="NYT_ENG_20050516.0286"><line>They consumed on average 33.3 grams of fat a day.</line></document><document name="APW_ENG_20050808.0126"><line>For women 65 and older with early-stage tumors _ the most common scenario _ the shift in size accounted for virtually all of the improvement in survival.</line></document><document name="APW_ENG_20050513.0945"><line>They found that the benefits of these drugs are remarkably persistent 15 years after diagnosis.</line></document><document name="APW_ENG_20050808.0126"><line>However, Dr. Barnett Kramer, associate director for disease prevention at the National Institutes of Health, noted that the study did not have information on how many of these tumors were found through mammograms or what treatments various groups of women received, so no direct conclusions about the value of these can be drawn.<annotation scu-count="0" sum-count="2" sums="3,35"/></line></document><document name="AFP_ENG_20050525.0641"><line>&quot;Women don't have to run marathons for the maximum benefit,&quot; she added.</line></document><document name="APW_ENG_20050513.0945"><line>However, the work is important in confirming the benefits over time from chemotherapy and hormone treatments, and will be reassuring to doctors and patients, she said.</line></document><document name="LTW_ENG_20050510.0106"><line>Even geography plays a role in how women are treated, he said.<annotation scu-count="0" sum-count="1" sums="42"/></line></document><document name="NYT_ENG_20050829.0289"><line>In the UNC tests, researchers performed sentinel-node biopsy before chemotherapy, modifying the technique slightly for larger cancers.<annotation scu-count="0" sum-count="1" sums="57"/></line></document><document name="NYT_ENG_20050425.0255"><line>A cancer drug cuts in half the risk that one type of breast cancer will recur after surgery, the National Cancer Institute and the drug's manufacturer announced Monday.<annotation scu-count="0" sum-count="1" sums="49"/></line></document><document name="NYT_ENG_20050829.0289"><line>If this node, called the sentinel, is clean, chances are the other nodes have not been affected.</line></document><document name="LTW_ENG_20050719.0134"><line>She hypothesizes they have lower rates of breast cancer and higher levels of circulating melatonin.</line></document><document name="NYT_ENG_20050829.0289"><line>Instead of removing 10 or more lymph nodes and analyzing all of them to look for cancer, this procedure removes only the node that is closest to the cancer and most likely to have it.</line></document><document name="NYT_ENG_20050516.0286"><line>The additional benefit from diet, Chlebowski said, was equivalent to adding a new drug to their regimen.</line></document><document name="LTW_ENG_20050510.0106"><line>She said atypical ductal hyperplasia should be closely monitored, but DCIS should be removed in most but probably not all women.</line><line>Sanders and Page examined specimens from 1950 to 1968 and followed the fate of the women who were diagnosed but untreated in what Sanders called the &quot;pre-mammographic era.&quot;</line></document><document name="NYT_ENG_20050829.0289"><line>It shows that sentinel-node biopsy, when performed before chemotherapy is given to shrink the tumor, is very reliable, the UNC researchers said.</line></document><document name="APW_ENG_20050808.0126"><line>Federal surveys show that the percent of women 40 and older who had a mammogram in the previous two years increased from 29 percent in 1987 to 70 percent in 2000.</line></document><document name="LTW_ENG_20050817.0111"><line>To obtain information about what adult women had eaten as preschoolers, the researchers asked the mothers of participants in the nurses study to fill out questionnaires asking how often their daughters had eaten 30 different food items.</line><line>Dr. Larry Norton, deputy physician in chief of the breast cancer program at Memorial Sloan-Kettering Cancer Center in New York, warned against over-interpreting the results.<annotation scu-count="0" sum-count="2" sums="12,13"/></line></document><document name="LTW_ENG_20050719.0134"><line>Laboratory studies by researchers at the University of Arizona have shown that breast cancer cells stop proliferating in melatonin's presence.</line></document><document name="LTW_ENG_20050817.0111"><line>The finding is the first of its kind and must be confirmed by other studies, said lead author Karin Michels, an associate professor at Harvard Medical School and clinical epidemiologist at Brigham and Women's Hospital in Boston.</line></document><document name="AFP_ENG_20050720.0687"><line>The study, published in the New England Journal of Medicine, gave evidence for the need for women whose biopsies of breast lesions proved benign to remain wary of the possibility that a malignancy could later develop.<annotation scu-count="0" sum-count="1" sums="43"/></line></document><document name="LTW_ENG_20050817.0111"><line>&quot;Only one food so distinctly stood out as being associated with breast cancer risk,&quot; Michels said, and that was the french fries.</line></document><document name="NYT_ENG_20050425.0255"><line>The announcement Monday came after the close of regular trading, in which Genentech's shares fell 41 cents to $69.43.</line></document><document name="NYT_ENG_20050829.0289"><line>Also, some surgeons advocate performing the sentinel-node biopsy procedure in women with large tumors only after chemotherapy, to discover how much of the tumor remains.</line></document><document name="NYT_ENG_20050425.0255"><line>The drug can cause heart problems, and the clinical trial data should be analyzed to see how severe these side effects are, he said.</line></document><document name="LTW_ENG_20050719.0134"><line>A growing number of scientists theorize that melatonin also suppresses the growth of cancer cells.<annotation scu-count="0" sum-count="1" sums="6"/></line></document><document name="NYT_ENG_20050516.0286"><line>Other studies have found that breast cancer is less likely to recur in women who lose weight after their initial treatment.<annotation scu-count="0" sum-count="3" sums="22,36,37"/></line></document><document name="APW_ENG_20050808.0126"><line>&quot;Even within the same stage category, the average tumor size is smaller today than it was 25 years ago,&quot; Elkin said.</line></document><document name="LTW_ENG_20050817.0111"><line>The dietary survey examined the childhood eating habits of participants in the Harvard Nurses' Health Study.<annotation scu-count="0" sum-count="1" sums="5"/></line></document><document name="LTW_ENG_20050719.0134"><line>&quot;This study brings us one step closer to understanding why night shift workers may be more likely to develop breast cancer.&quot;<annotation scu-count="1" sum-count="1" sums="43"><scu uid="4" label="Night shift workers have a higher risk of breast cancer" weight="3"/></annotation></line></document><document name="NYT_ENG_20050829.0289"><line>The painful operation sometimes causes swelling, numbness and infection.<annotation scu-count="0" sum-count="1" sums="18"/></line></document><document name="LTW_ENG_20050510.0106"><line>As a result of the new conclusions, older women may want to leave low-grade DCIS untreated, Sanders said.</line></document><document name="NYT_ENG_20050425.0255"><line>Conference rules, she said, prohibit discussion of results beforehand.<annotation scu-count="0" sum-count="1" sums="12"/></line><line>Moreover, in the last few weeks two other trials involving another Genentech cancer drug, Avastin, were stopped early after that drug, already approved for colon cancer, was shown to work for lung cancer and breast cancer as well.</line><line>Perez said the reduction in disease recurrence was &quot;the largest improvement in clinical research in breast cancer in my lifetime.&quot;<annotation scu-count="0" sum-count="2" sums="36,37"/></line></document><document name="APW_ENG_20050808.0126"><line>An inch is about 2.5 centimeters.<annotation scu-count="0" sum-count="1" sums="12"/></line><line>&quot;In addition to finding more small tumors, we're also finding less big tumors.&quot;</line><line>&quot;You don't know how the cancers were diagnosed so there's no way to link any type of testing or physical examination... with the results of this study,&quot; he said.</line></document><document name="LTW_ENG_20050719.0134"><line>&quot;This is an interesting bit of new information and it will be put in context with other studies that have shown similar results and those that have shown no association,&quot; said Dr. Brian O'Hea, director of the Carol M. Baldwin Breast Care Center at Stony Brook University Hospital.</line></document><document name="AFP_ENG_20050720.0687"><line>&quot;Women who have a breast biopsy that is benign must discuss the possibility of additional risks with their doctors,&quot; Hartmann said.<annotation scu-count="0" sum-count="1" sums="57"/></line></document><document name="APW_ENG_20050808.0126"><line>It was conducted by doctors at Memorial Sloan-Kettering Cancer Center in New York and used a federal government's database that includes nine cancer registries covering 10 percent of the U.S. population.</line><line>Next, researchers compared five-year survival rates for these time periods, taking into account the shift in tumor size.</line></document><document name="NYT_ENG_20050829.0289"><line>Typically, surgeons remove 10 or more lymph nodes from the patient's armpit to look for the spread of cancer.</line></document><document name="APW_ENG_20050808.0126"><line>Size made a much bigger difference for older women than younger ones.</line><line>Survival has increased, but experts have argued over how much of that is because of better drugs or tumors being found at earlier stages.</line><line>On the Net:</line></document><document name="APW_ENG_20050513.0945"><line>Several studies have followed women for 15 years, but no single study has been big enough to reliably show the full scope.</line></document><document name="APW_ENG_20050808.0126"><line>Looked at another way, the shift in size accounted for 61 percent of the improvement in survival.</line></document><document name="LTW_ENG_20050510.0106"><line>Sanders and Page report the results of their research in Cancer, an American Cancer Society publication.<annotation scu-count="0" sum-count="2" sums="18,5"/></line></document><document name="NYT_ENG_20050829.0289"><line>When the dye used in the procedure can't get down the road, sometimes it goes around on other pathways, identifying the wrong lymph nodes.</line></document><document name="LTW_ENG_20050510.0106"><line>But even with new insight into a type of breast cancer doctors call ductal carcinoma in situ, or DCIS, there is still debate over how to treat it: Do all patients need surgery and radiation, or can some skip them?<annotation scu-count="0" sum-count="1" sums="16"/></line></document><document name="NYT_ENG_20050516.0286"><line>It could be the small amount of fat the women ate, or it could be that they lost weight.</line></document><document name="AFP_ENG_20050525.0641"><line>Women stricken with breast cancer can boost their chances of survival by 50 percent with some exercise, according to a study published Wednesday.<annotation scu-count="1" sum-count="8" sums="11,23,25,29,40,41,49,55"><scu uid="10" label="Exercise increases breast cancer survival" weight="4"/></annotation></line></document><document name="NYT_ENG_20050425.0255"><line>All had operable cancer that in most cases had spread to the lymph nodes.</line></document><document name="LTW_ENG_20050719.0134"><line>During daylight or exposure to bright lights, the hormone melatonin is suppressed.</line></document><document name="LTW_ENG_20050817.0111"><line>&quot;I wouldn't go out and change Americans' dietary habits on the basis of this, but it's certainly worth pursuing the hypothesis with additional research,&quot; he said.</line></document><document name="NYT_ENG_20050425.0255"><line>The 20 to 30 percent of tumors that Herceptin is approved to treat have an abnormally high level of this protein, called HER2.</line><line>But he said he thought doctors should wait for the full data before deciding whether to give Herceptin to patients after surgery.</line></document><document name="APW_ENG_20050513.0945"><line>The last overview, in 2000, found that better treatments over the preceding decade had slashed breast cancer death rates in Britain and the United States by one-quarter among some groups.</line></document><document name="LTW_ENG_20050817.0111"><line>A study examining the role childhood diet plays in breast cancer has found an association between eating French fries regularly during the preschool years and developing breast cancer as an adult.<annotation scu-count="1" sum-count="7" sums="11,14,25,29,41,51,55"><scu uid="6" label="girls who frequently ate French fries as preschoolers have a higher risk of breast cancer" weight="3"/></annotation></line></document><document name="APW_ENG_20050513.0945"><line>The therapies studied in the Lancet paper have been proven, she said, but the next challenge is to cure even more women with newer and more targeted drugs.<annotation scu-count="0" sum-count="2" sums="32,38"/></line></document><document name="NYT_ENG_20050425.0255"><line>For certain cancers, so are hormonal drugs like tamoxifen or the newer aromatase inhibitors.<annotation scu-count="0" sum-count="2" sums="37,6"/></line></document><document name="APW_ENG_20050513.0945"><line>About 1.15 million new cases of breast cancer are diagnosed every year worldwide.</line></document><document name="NYT_ENG_20050425.0255"><line>Some experts said the results of two clinical trials were so strong that the drug, Genentech's Herceptin, would soon be added to chemotherapy as a standard part of postsurgical treatment for some women.</line></document><document name="NYT_ENG_20050516.0286"><line>Women in the study who were assigned to follow a low-fat diet had more than a 20 percent reduction in their rate of recurrence over five years, the investigators found.<annotation scu-count="1" sum-count="1" sums="19"><scu uid="3" label="Studies have shown that low-fat diets are effective " weight="4"/></annotation></line></document><document name="NYT_ENG_20050425.0255"><line>The two trials, which began enrolling patients in 2000, involved a combined total of more than 5,000 women, though the analysis that resulted in the trials' being stopped was based on only 3,300 of them.</line></document><document name="APW_ENG_20050808.0126"><line>Saslow had no role in the study, which was being published Monday online by the society's journal Cancer and will be in its Sept. 15 print edition.<annotation scu-count="0" sum-count="3" sums="29,55,8"/></line></document><document name="LTW_ENG_20050510.0106"><line>This made the cases especially compelling, Sanders said, because it allowed the team to determine how the disorder progresses over many decades.</line></document><document name="LTW_ENG_20050719.0134"><line>Night shift workers who had low levels of the body's vital &quot;sleep hormone,&quot; were significantly more likely to develop breast cancer than those who were awake during the day but got plenty of shut-eye at night, a team of scientists will report Wednesday.</line></document><document name="NYT_ENG_20050829.0289"><line>Such patients usually get chemotherapy to shrink the tumor before surgery, to decrease chances of recurrence and, for a small number of women, to make it feasible to have a lumpectomy rather than a mastectomy.<annotation scu-count="0" sum-count="1" sums="32"/></line></document><document name="APW_ENG_20050808.0126"><line>&quot;It isn't necessarily because treatment works better for certain women, it reflects who's getting more,&quot; because younger women are more likely to receive chemotherapy, Elkin said.</line></document><document name="NYT_ENG_20050829.0289"><line>&quot;Now we need a national study.&quot;</line></document><document name="NYT_ENG_20050425.0255"><line>Indeed, the company, based in South San Francisco, Calif., said Monday that with demand for Avastin and Herceptin expected to grow faster than expected, it would have to review its plans to make sure it has enough manufacturing capacity.</line></document><document name="NYT_ENG_20050516.0286"><line>It was, researchers said, the first time that a large, rigorous study showed that diet could have any impact on any cancer.</line></document><document name="NYT_ENG_20050425.0255"><line>After four years, only 15 percent of the women who got the drug combined with traditional chemotherapy had a relapse, compared with 33 percent of the women who got only chemotherapy, Perez said.</line></document><document name="APW_ENG_20050808.0126"><line>For women with local-stage breast cancers, survival rose from nearly 91 percent to more than 97 percent, but was only 93 percent after adjusting for smaller tumors.</line></document><document name="NYT_ENG_20050425.0255"><line>&quot;This is a practice-changing result,&quot; said Dr. Edith A. Perez of the Mayo Clinic in Jacksonville, Fla., the principal investigator for one of the trials.</line><line>Herceptin, given intravenously, is intended to block a particular protein that juts out of tumor cells and spurs them to grow when it is activated.</line></document><document name="NYT_ENG_20050516.0286"><line>But 181 of 1,462 women, or 12.4 percent, who were assigned to maintain their usual diet had their cancer return.</line></document><document name="APW_ENG_20050808.0126"><line>More than 265,000 breast tumors were analyzed.<annotation scu-count="0" sum-count="1" sums="32"/></line></document><document name="APW_ENG_20050513.0945"><line>The analysis found that where both chemotherapy and hormone therapy were appropriate, the risk of death within 15 years of diagnosis could be cut in half, so that if a 50-year-old woman had a 1-in-5 chance of dying from her cancer, the drugs could bring the risk down to 1 in 10.<annotation scu-count="1" sum-count="1" sums="19"><scu uid="13" label="Combined chemotherapy and hormone therapy cut death in half within 15 years " weight="1"/></annotation></line></document><document name="APW_ENG_20050808.0126"><line>Two-thirds of breast cancers today are diagnosed at the local stage, when they're still confined to the breast; in the 1970s, only half were.</line></document><document name="AFP_ENG_20050720.0687"><line>The Mayo team, which is examining risk factors related to breast cancer, showed after tests on 9,087 women that the most common types of benign lesions, those classified as non-proliferative, do not increase the risk of a susequent malignancy.<annotation scu-count="0" sum-count="1" sums="20"/></line></document><document name="LTW_ENG_20050817.0111"><line>It's really new,&quot; she said, adding, &quot;It could be due to chance.&quot;</line></document><document name="AFP_ENG_20050525.0641"><line>&quot;The most logical explanation is that physical activity lowers hormone levels, and the lower hormone levels reduce the chances of a recurrence,&quot; Homes said.</line></document><document name="LTW_ENG_20050719.0134"><line>&quot;Two or three years ago we probably would have been reluctant to say there was an association,&quot; said Dr. Eva Schernhammer, an epidemiologist at Brigham and Women's Hospital.</line></document><document name="NYT_ENG_20050829.0289"><line>He acknowledged the controversy in medical circles about the surgery, which uses a dye injection to stain the first affected lymph node.</line></document><document name="APW_ENG_20050808.0126"><line>The study wasn't designed to determine the value of mammograms or treatments.</line></document><document name="AFP_ENG_20050525.0641"><line>&quot;Women with breast cancer have little to lose and much to gain from exercise,&quot; Holmes said.<annotation scu-count="1" sum-count="1" sums="20"><scu uid="10" label="Exercise increases breast cancer survival" weight="4"/></annotation></line></document><document name="NYT_ENG_20050829.0289"><line>The study suggests that sentinel-node biopsy is an option that might benefit all women with breast cancers, said Ollila, associate professor of surgery at UNC and a member of the UNC Lineberger Comprehensive Cancer Center.</line></document><document name="LTW_ENG_20050719.0134"><line>Schernhammer, who reported her results in Wednesday's Journal of the National Cancer Institute, said women exposed to light at night had measurably lower levels of a melatonin breakdown product in urine.</line></document><document name="NYT_ENG_20050425.0255"><line>The results are more good news for Genentech.</line></document><document name="APW_ENG_20050808.0126"><line>Of regional-stage cancers _ those that spread to nearby tissue or lymph nodes but not widely throughout the body _ the portion that were smaller than 2 centimeters rose from one-fifth to one-third.</line></document><document name="AFP_ENG_20050720.0687"><line>Women with benign breast lesions bear a higher risk of eventually developing breast cancer, according to a study released Wednesday in the United States.<annotation scu-count="1" sum-count="14" sums="10,13,14,20,23,25,29,33,37,40,41,43,44,51"><scu uid="5" label="LInk between breast lesions and cancer" weight="3"/></annotation></line></document><document name="LTW_ENG_20050817.0111"><line>Michels noted these recollections may have been unreliable, especially when made by mothers who already knew their daughters had breast cancer.</line></document><document name="APW_ENG_20050808.0126"><line>&quot;This really helps to show the importance of screening,&quot; said Debbie Saslow, who heads breast cancer research at the American Cancer Society.<annotation scu-count="0" sum-count="1" sums="36"/></line></document><document name="AFP_ENG_20050525.0641"><line>The study was conducted among some 3,000 nurses diagnosed with different stages of breast cancer between 1984-1998 and who were monitored until June 2002.<annotation scu-count="0" sum-count="1" sums="40"/></line></document><document name="APW_ENG_20050808.0126"><line>&quot;We don't in any way want to diminish the benefits we've seen from advances in treatment because they've been enormous,&quot; said lead researcher Elena Elkin.</line></document><document name="NYT_ENG_20050516.0286"><line>Of them, 975 were assigned to a diet so low in fat that, Chlebowski said, it was about as low as possible without being a vegetarian diet.</line><line>But he and independent experts at the meeting and elsewhere said the study's findings, which were only marginally statistically significant, must be confirmed before recommending that women with breast cancer follow such a diet.</line></document><document name="NYT_ENG_20050425.0255"><line>Perez said the results would be presented at the American Society of Clinical Oncology meeting in Orlando, Fla., next month.</line></document><document name="NYT_ENG_20050829.0289"><line>In an average of 36 months of post-treatment follow-up, none of the patients showed progression of cancer in the lymph nodes.</line></document><document name="NYT_ENG_20050516.0286"><line>The 1,462 women in the control group, who were instructed to follow their usual diet, consumed 51.3 grams of fat a day.</line></document></collection>